contact@tendernotify.co.uk
Award,contract Find a Tender Complete
Save tender

NHS National Branded Interim - 1 June 2026

Buyer: NHS England

Deadline
Not available — this notice may describe a possible future opportunity.
Region
Not specified
Value
£529,090,780
Type
Award,contract
SME fit
Duration

Description

Provision of an NHS National Branded Interim - 1 June 2026 01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months

Awarded to

Aspire Pharma Limited £529,090,780 NOVARTIS PHARMACEUTICALS UK LIMITED £529,090,780 SYNCHRONY (CNX THERAPEUTICS LIMITED) £529,090,780 ACCORD-UK LTD £529,090,780 ASTRAZENECA UK LIMITED £529,090,780 AVENTIS PHARMA LIMITED £529,090,780 CAMURUS AB £529,090,780 CIPLA (EU) LIMITED £529,090,780 CONSILIENT HEALTH (UK) LIMITED £529,090,780 CST PHARMA LIMITED £529,090,780 DAY LEWIS MEDICAL LIMITED £529,090,780 ESSENTIAL PHARMA LIMITED £529,090,780 Esteve Pharmaceuticals Ltd £529,090,780 EUMEDICA PHARMA LTD £529,090,780 FLEXIPHARM AUSTRADING LIMITED £529,090,780 FLYNN PHARMA LIMITED £529,090,780 GLENMARK PHARMACEUTICALS EUROPE LIMITED £529,090,780 GRUNENTHAL LIMITED £529,090,780 JANSSEN-CILAG LIMITED £529,090,780 LOGIXX PHARMA LIMITED £529,090,780 Lupin Healthcare (UK) Limited £529,090,780 MARTINDALE PHARMA (MACARTHYS LABORATORIES LIMITED) £529,090,780 MEDAC PHARMA LLP £529,090,780 MERCK SHARP & DOHME (UK) LIMITED £529,090,780 Mercury Pharmaceuticals Limited £529,090,780 Morningside Pharmaceuticals Limited £529,090,780 MSN Laboratories Europe Limited £529,090,780 NAPP PHARMACEUTICALS LIMITED £529,090,780 NEURAXPHARM UK LIMITED £529,090,780 NORGINE PHARMACEUTICALS LIMITED £529,090,780 ORPHALAN UK LTD £529,090,780 PFIZER LIMITED £529,090,780 RENASCIENCE PHARMA LIMITED £529,090,780 Rosemont Pharmaceuticals Limited £529,090,780 SANTEN UK LIMITED £529,090,780 SELECTIVE SUPPLIES LIMITED £529,090,780 SERB LTD £529,090,780 SWEDISH ORPHAN BIOVITRUM LTD £529,090,780 STIRLING ANGLIAN PHARMACEUTICALS LIMITED £529,090,780 VIATRIS UK HEALTHCARE LIMITED (MYLAN) £529,090,780 SYRI LIMITED £529,090,780 Takeda UK Limited £529,090,780 Teva UK Limited £529,090,780 THEA PHARMACEUTICALS LIMITED £529,090,780 THORNTON & ROSS LIMITED £529,090,780 UNICORN PHARMACEUTICALS LIMITED £529,090,780 ZENTIVA PHARMA UK LIMITED £529,090,780 Zydus Pharmaceuticals UK Ltd £529,090,780 ASCEND LABORATORIES (UK) LIMITED £529,090,780 NORDIC PHARMA LIMITED £529,090,780 SUN PHARMA UK LIMITED £529,090,780
Quick actions
Key details
CPV category
Procurement method
Open procedure
Published
16 Apr 2026 16:01
VCSE suitable
Reference
OCID
ocds-h6vhtk-05fbbc
Notice ID
C409236
In our database since
17 Aug 2026